Minerva Neurosciences | NERV - Liquidités





Liquidités Changement Date
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Adma Biologics USD 87.63M 26.24M 2025-12
ALKERMES USD 351.55M 37.02M 2026-03
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
AstraZeneca USD 7.56B 1.85B 2026-03
BioCryst Pharmaceuticals USD 335.91M 251.83M 2025-12
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Cipla INR 7.96B 39.9M 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 90.6M 83.14M 2025-12
CSL USD 2.16B 633M 2025-06
Eli Lilly USD 5.28B 1.99B 2026-03
Esperion Therapeutics USD 92.45M 6.39M 2025-09
GlaxoSmithKline GBP 3.44B 292M 2026-03
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
J&J USD 21.69B 1.98B 2026-03
Merck USD 5.33B 9.24B 2026-03
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Neurocrine Biosciences USD 266.5M 446.5M 2026-03
Novartis USD 6.88B 4.56B 2026-03
Novavax USD 240.63M 27.39M 2025-12
Pfizer USD 1.7B 561M 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Takeda JPY 654.94B 26.55B 2025-12
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12